Lipospheres in Drug Targets and Delivery: Approaches, Methods, and Applications [1 ed.] 9780849316920, 0849316928

Citation preview

Lipospheres in Drug Targets and Delivery Approaches, Methods, and Applications

© 2005 by CRC Press LLC

Lipospheres in Drug Targets and Delivery Approaches, Methods, and Applications

EDITED BY

Claudio Nastruzzi

CRC PR E S S Boca Raton London New York Washington, D.C. © 2005 by CRC Press LLC

Library of Congress Cataloging-in-Publication Data Lipospheres in drug targets and delivery : approaches, methods, and applications / edited by Claudio Nastruzzi. p. ; cm. Includes bibliographical references and index. ISBN 0-8493-1692-8 (alk. paper) 1. Liposomes—Therapeutic use. 2. Microspheres (Pharmacy). 3. Nanoparticles. 4. Drug carriers (Pharmacy). 5. Drug targeting. [DNLM: 1. Liposomes—therapeutic use. 2. Drug Delivery Systems—methods. 3. Lipids—therapeutic use. QU 93 L7658 2004] I. Nastruzzi, Claudio. II. Title. RS201.L55L595 2004 615′.7--dc22

2004051936

This book contains information obtained from authentic and highly regarded sources. Reprinted material is quoted with permission, and sources are indicated. A wide variety of references are listed. Reasonable efforts have been made to publish reliable data and information, but the author and the publisher cannot assume responsibility for the validity of all materials or for the consequences of their use. Neither this book nor any part may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, microfilming, and recording, or by any information storage or retrieval system, without prior permission in writing from the publisher. All rights reserved. Authorization to photocopy items for internal or personal use, or the personal or internal use of specific clients, may be granted by CRC Press LLC, provided that $1.50 per page photocopied is paid directly to Copyright Clearance Center, 222 Rosewood Drive, Danvers, MA 01923 USA. The fee code for users of the Transactional Reporting Service is ISBN 0-8493-16928/05/$0.00+$1.50. The fee is subject to change without notice. For organizations that have been granted a photocopy license by the CCC, a separate system of payment has been arranged. The consent of CRC Press LLC does not extend to copying for general distribution, for promotion, for creating new works, or for resale. Specific permission must be obtained in writing from CRC Press LLC for such copying. Direct all inquiries to CRC Press LLC, 2000 N.W. Corporate Blvd., Boca Raton, Florida 33431. Trademark Notice: Product or corporate names may be trademarks or registered trademarks, and are used only for identification and explanation, without intent to infringe.

Visit the CRC Press Web site at www.crcpress.com © 2005 by CRC Press LLC No claim to original U.S. Government works International Standard Book Number 0-8493-1692-8 Library of Congress Card Number 2004051936 Printed in the United States of America 1 2 3 4 5 6 7 8 9 0 Printed on acid-free paper © 2005 by CRC Press LLC

Preface Colloidal drug carriers, such as liposomes and lipid nanoparticles, are able to modify the in vivo distribution of associated substances. They, therefore, can be used to improve the therapeutic index of drugs by increasing their efficacy or reducing their toxicity. If these delivery systems are carefully designed with respect to the target and route of administration, they help us to overcome some of the delivery problems posed by new classes of active molecules, such as peptides, proteins, genes, and oligonucleotides. They may also extend the therapeutic potential of established drugs, such as doxorubicin and amphotericin B. This book describes the use of lipid-based nano- and microparticulate carriers in such applications. It presents innovative methods of delivering active biochemicals to different systems, discusses lipospheres as a technical solution to problems associated with controlled release of biochemicals, covers lipospheres as carriers for vaccines, and finally provides procedures for specific applications and describes biological systems. With the identification, characterization, and cloning of specific growth factors, recombinant proteins are now widely used in the clinic. The use of recombinant hematopoietic growth factors has, for example, allowed the clinical manipulation of the hematopoietic system. Recombinant human granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor are now widely used to mobilize hematopoietic stem cells, thereby providing a source of hematopoietic stem cells for autologous or allogeneic transplantation. However, one disadvantage associated with the use of most recombinant molecules is their rapid clearance. Because of this rapid clearance, recombinant molecules require repeated administration to achieve biological efficacy. Initially, continuous infusion was used to address this pharmacological deficiency. Continuous infusion has the advantage of delivering drugs in a controlled manner and is particularly appropriate when it is important to maintain constant plasma drug concentrations. However, the requirement for continuous venous access and the use of ambulatory pumps limits its use. In this context, other approaches have been developed to improve the pharmacokinetic and pharmacodynamic properties of recombinant proteins in vivo. These have included the addition of polyethylene glycol to the recombinant molecules (PEGylation) and the use of sustained-release delivery systems. One goal of these approaches is to achieve clinical efficacy and lower the number of administrations, possibly to single injections, and thereby increase patient compliance. In addition to improving the pharmacokinetic and pharmacodynamic profile of recombinant molecules, sustained release may also increase the biological activity of specific molecules. Moreover, it should be acknowledged that the use of an efficient carrier for nucleic acid–based medicines is considered to be a determinant factor for the successful © 2005 by CRC Press LLC

application of gene therapy. However, the drawbacks associated with the use of viral vectors, namely, those related to safety problems, have prompted investigators to develop alternative methods for gene delivery, with cationic lipid-based systems being the most representative systems. Despite extensive research in the last decade on the use of cationic liposomes as gene transfer vectors, and the development of elegant strategies to enhance their biological activity, these systems are still far from being viable alternatives to the use of viral vectors in gene therapy. Finally, in this book considerations are made regarding the structure–activity relationships of cationic liposphere/DNA complexes, and the key formulations are presented and discussed in terms of their effect on biological activity.

© 2005 by CRC Press LLC

Editor

Claudio Nastruzzi was born in Ferrara, Italy, on March 29, 1958. In 1983, he earned his undergraduate degree in pharmaceutical chemistry at the University of Ferrara, and in the late 1980s he was a fellow at the university’s Department of Pharmaceutical Science, working on natural compound synthesis (prostaglandins and leukotrienes) and the characterization of isosazolic and isosazolinic nuclei reactivity. In 1988, he obtained his Ph.D. in pharmaceutical science with a dissertation on the synthesis and antitumor and antimetastatic activity of aromatic polyamidines. During the late 1990s, Dr. Nastruzzi worked with Professor P. L. Luisi as a postdoctoral fellow at the Institute for Polymers at the Swiss Federal Institute of Technology in Zürich. As a postdoctoral fellow at the Department of Pharmaceutical Sciences at the University of Ferrara, he focused on the production and characterization of liposomes specially designed for retinoid delivery, as well as on biophysical studies and activity of in vitro cultured cell lines. In 1991, he obtained a researcher position in this department, where he devoted his energy to the production of microspheres, liposomes, and microemulsions for the controlled delivery of biological response modifiers. Since 1998, Dr. Nastruzzi has been an associate professor in the Department of Chemistry and Pharmaceutical Technology at the University of Perugia, Italy. His main topics of interest include the production and characterization of innovative © 2005 by CRC Press LLC

dermatologic and cosmetic formulations for dermal and transdermal delivery (phospholipid-based microemulsion gels, cubic phases, liposomes, and niosomes); the production and characterization of microspheres and solid lipid microparticles; and liposome-based formulations for gene delivery. Dr. Nastruzzi has published more than 90 papers in international journals and has presented more than 80 contributions to national and international congresses.

© 2005 by CRC Press LLC

Contributors Heike Bunjes Department of Pharmaceutical Technology Friedrich Schiller University of Jena Jena, Germany

Karsten Mäder Institute of Pharmaceutics and Biopharmacy Martin Luther University of Halle Halle, Germany

Rita Cortesi Department of Pharmaceutical Sciences University of Ferrara Ferrara, Italy

Wolfgang Mehnert Department of Pharmaceutical Technology Free University of Berlin Berlin, Germany

Abraham J. Domb Department of Medicinal Chemistry and Natural Products Hebrew University of Jerusalem Jerusalem, Israel Elisabetta Esposito Department of Pharmaceutical Sciences University of Ferrara Ferrara, Italy Aviva Ezra Department of Medicinal Chemistry and Natural Products Hebrew University of Jerusalem Jerusalem, Israel Achim Göpferich Department of Pharmaceutical Technology University of Regensburg Regensburg, Germany Stephanie Könnings Department of Pharmaceutical Technology University of Regensburg Regensburg, Germany

© 2005 by CRC Press LLC

Boaz Mizrahi Department of Medicinal Chemistry and Natural Products Hebrew University of Jerusalem Jerusalem, Israel R.H. Müller Department of Pharmaceutics, Biopharmaceutics, and Biotechnology Free University of Berlin Berlin, Germany Carsten Olbrich Schering AG Berlin, Germany Monika Schäfer-Korting Department of Pharmacology and Toxicology Free University of Berlin Berlin, Germany Nadja Schöler Schering AG Berlin, Germany

Kerstin Tabatt PenCef Pharma GmbH Berlin, Germany

© 2005 by CRC Press LLC

Sylvia A. Wissing Drug Delivery Services GmbH Kronshagen, Germany

Table of Contents Chapter 1 Solid Lipid Nanoparticles — Concepts, Procedures, and Physicochemical Aspects.......................................................................................................................1 Karsten Mäder and Wolfgang Mehnert Chapter 2 Production of Lipospheres for Bioactive Compound Delivery ..............................23 Elisabetta Esposito, Rita Cortesi, and Claudio Nastruzzi Chapter 3 Characterization of Solid Lipid Nano- and Microparticles ....................................41 Heike Bunjes Chapter 4 Lipospheres as Delivery Systems for Peptides and Proteins..................................67 Stephanie Könnings and Achim Göpferich Chapter 5 Lipospheres for Vaccine Delivery ...........................................................................87 Abraham J. Domb, Aviva Ezra, and Boaz Mizrahi Chapter 6 Solid Lipid Nanoparticles: Interaction with Cells, Cytokine Production, and Enzymatic Degradation .........................................................................................101 Carsten Olbrich, Kerstin Tabatt, Sylvia A. Wissing, Nadja Schöler, and R.H. Müller Chapter 7 Delivery of Lipophilic Compounds with Lipid Nanoparticles — Applications in Dermatics and for Transdermal Therapy ..........................................................127 Monika Schäfer-Korting and Wolfgang Mehnert Chapter 8 Cationic Lipospheres as Delivery Systems for Nucleic Acid Molecules.............143 Rita Cortesi, Elisabetta Esposito, and Claudio Nastruzzi

© 2005 by CRC Press LLC